Cimpress Shifts Exec Pay, Seeks Shareholder Mandate at 2025 AGM

Ticker: CMPR · Form: DEF 14A · Filed: Oct 28, 2025 · CIK: 1262976

Sentiment: mixed

Topics: Executive Compensation, Corporate Governance, Shareholder Meeting, Director Reappointment, Share Dilution, Financial Performance, Proxy Statement

Related Tickers: CMPR, CRD.A, WAC

TL;DR

**CMPR is doubling down on financial performance with new exec comp, but watch out for potential dilution from renewed share issuance authority.**

AI Summary

CIMPRESS plc (CMPR) is holding its 2025 Annual General Meeting on December 17, 2025, to address several key proposals, including the reappointment of two directors, an advisory vote on executive compensation, and the renewal of share issuance authorities. Robert S. Keane, Founder, Chairman, and CEO, who has led Cimpress to $3.4 billion in revenue in fiscal year 2025, is up for reappointment to the Board for a three-year term. Scott J. Vassalluzzo, representing Prescott General Partners LLC, which holds 14.6% of outstanding shares, is also recommended for reappointment. The company's executive compensation strategy for fiscal year 2025 shifted its long-term incentive awards to Performance Share Units (PSUs) based on financial metrics: Revenue (20%), Adjusted EBITDA (40%), and Unlevered Adjusted Free Cash Flow (40%), a change from fiscal year 2024 where Revenue was 10% and the other two were 45% each. This new PSU design, vesting over four years, aims to balance in-year financial performance with multi-year share price appreciation, moving away from prior 3YMA-based PSUs due to retention and motivation concerns. Shareholders will also vote on renewing the Board's authority to issue up to 20% of unissued ordinary shares and to opt out of statutory preemption rights until June 17, 2027.

Why It Matters

This DEF 14A filing is crucial for investors as it outlines CIMPRESS's governance and compensation strategies, directly impacting shareholder value. The shift in executive compensation to performance-based PSUs tied to revenue, EBITDA, and free cash flow signals a renewed focus on core financial metrics, potentially driving stronger operational performance. For employees, the compensation structure influences retention and motivation, especially for top talent in a competitive market. The proposed renewal of share issuance authority could dilute existing shareholders if exercised, but also provides the company with flexibility for strategic growth or acquisitions, a key competitive lever in the digital printing and mass customization industry against rivals like Shutterfly or VistaPrint's other competitors. The advisory vote on executive compensation offers a direct channel for shareholders to influence corporate governance and ensure alignment with their interests.

Risk Assessment

Risk Level: medium — The company is seeking to renew authority to issue up to 20% of its issued and outstanding share capital and to opt out of statutory preemption rights until June 17, 2027. This could lead to significant shareholder dilution if a large number of shares are issued without existing shareholders having the first right to purchase them. While the shift in executive compensation to financial metrics (Revenue 20%, Adjusted EBITDA 40%, Unlevered Adjusted Free Cash Flow 40%) aims to align incentives, the effectiveness of this new structure in driving long-term value remains to be seen.

Analyst Insight

Investors should carefully review the proposed share issuance authority and preemption rights waiver, considering the potential for dilution. Engage with the advisory vote on executive compensation to signal approval or disapproval of the new PSU structure, which prioritizes specific financial metrics over prior 3YMA-based PSUs.

Key Numbers

Key Players & Entities

FAQ

What are the key proposals for Cimpress's 2025 Annual General Meeting?

Cimpress's 2025 Annual General Meeting, scheduled for December 17, 2025, includes proposals to reappoint Robert S. Keane and Scott J. Vassalluzzo to the Board, an advisory vote on executive compensation, and the renewal of the Board's authority to issue up to 20% of ordinary shares and opt out of preemption rights until June 17, 2027.

How has Cimpress's executive compensation structure changed for fiscal year 2025?

For fiscal year 2025, Cimpress's executive compensation shifted to Performance Share Units (PSUs) with performance targets based on Revenue (20%), Adjusted EBITDA (40%), and Unlevered Adjusted Free Cash Flow (40%). This represents a change from fiscal year 2024, where Revenue was weighted at 10% and the other two metrics at 45% each, and a move away from prior 3YMA-based PSUs.

Who are the directors up for reappointment at the Cimpress 2025 AGM?

Robert S. Keane, Founder, Chairman, and CEO, and Scott J. Vassalluzzo, a Non-Employee Director and Managing Member of Prescott General Partners LLC, are both recommended for reappointment to Cimpress's Board of Directors for three-year terms ending at the 2028 annual general meeting.

What is the significance of Cimpress renewing its authority to issue ordinary shares?

Renewing the authority to issue up to 20% of authorized but unissued ordinary shares and to opt out of statutory preemption rights provides Cimpress's Board with flexibility for future capital raises, acquisitions, or other strategic corporate actions. However, it also carries the risk of diluting existing shareholders if new shares are issued without preemption rights.

When and where will Cimpress's 2025 Annual General Meeting be held?

Cimpress plc will hold its 2025 Annual General Meeting of Shareholders on Wednesday, December 17, 2025, at 6:00 p.m. Dublin Time, at the offices of Matheson LLP, 70 Sir John Rogerson's Quay, Dublin 2, D02 R296, Ireland.

What is the role of the advisory vote on executive compensation for Cimpress shareholders?

The advisory vote on executive compensation allows Cimpress shareholders to express their approval or disapproval of the compensation paid to named executive officers. While non-binding, the Compensation Committee considers shareholder feedback when designing future executive compensation programs, as demonstrated by the company's response to the 2023 'say-on-pay' vote.

What financial performance did Cimpress achieve in fiscal year 2025?

Cimpress achieved $3.4 billion in revenue for its fiscal year 2025. This figure is cited as a key achievement under the leadership of Robert S. Keane, who founded the company in January 1995.

Who is Cimpress's statutory auditor and what is being proposed regarding their remuneration?

PricewaterhouseCoopers Ireland is Cimpress's statutory auditor under Irish law. Shareholders are being asked to reappoint them until the 2026 annual general meeting and to authorize the Board of Directors or Audit Committee to determine their remuneration.

What is the voting threshold for the special resolution at the Cimpress AGM?

Proposal 5, which concerns renewing the authority to opt out of statutory preemption rights under Irish law, will be proposed as a special resolution. This requires at least 75% of the votes cast to be in favor of the resolution for it to pass, a higher threshold than the simple majority required for ordinary resolutions.

How can Cimpress shareholders access proxy materials for the 2025 Annual General Meeting?

Cimpress shareholders can access proxy materials, including the Proxy Statement and 2025 Annual Report, online at http://www.viewproxy.com/Cimpress/2025. Paper copies can be requested by emailing ir@cimpress.com or writing to Cimpress plc, c/o Cimpress USA Incorporated, Attention Investor Relations, 275 Wyman Street, Waltham, MA 02451, USA.

Risk Factors

Industry Context

Cimpress operates in the highly competitive global online printing market. Key trends include increasing demand for personalized and on-demand printing, the ongoing digital transformation of customer interactions, and the need for efficient supply chain and logistics management. Companies in this sector face pressure to innovate in product offerings and customer experience while managing costs effectively.

Regulatory Implications

The company's request to renew its authority to issue shares and opt out of preemption rights requires shareholder approval and is subject to corporate governance regulations. Compliance with disclosure requirements for executive compensation and financial reporting, as mandated by the SEC, is also critical.

What Investors Should Do

  1. Review the proposed reappointment of Robert S. Keane and Scott J. Vassalluzzo, considering their experience and the company's performance under their tenure.
  2. Evaluate the revised executive compensation structure, particularly the weighting of PSUs, and its alignment with shareholder interests and long-term value creation.
  3. Consider the implications of granting the Board authority to issue up to 20% of shares and opt out of preemption rights, assessing potential dilution versus strategic flexibility.

Key Dates

Glossary

DEF 14A
A proxy statement filed by public companies with the U.S. Securities and Exchange Commission (SEC) to solicit shareholder votes. (This document contains the information and proposals being presented to Cimpress shareholders for their vote at the Annual General Meeting.)
Performance Share Units (PSUs)
A type of long-term incentive award where the number of shares ultimately received by the executive depends on the achievement of specific performance goals. (Cimpress has shifted its long-term executive compensation to PSUs based on financial metrics, indicating a focus on performance-based rewards.)
Adjusted EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization, adjusted for certain non-recurring or non-operational items. (A key financial metric used in Cimpress's executive compensation, weighted at 40% for FY25 PSUs, indicating its importance in performance evaluation.)
Unlevered Adjusted Free Cash Flow
A measure of a company's cash flow available to all investors (debt and equity holders) after operating expenses and capital expenditures, adjusted for certain items. (Another key financial metric for executive compensation, weighted at 40% for FY25 PSUs, reflecting the company's focus on cash generation.)
Statutory Preemptive Rights
The right of existing shareholders to maintain their proportional ownership by being offered new shares before they are offered to the public. (Cimpress is seeking shareholder approval to opt out of these rights, which could allow the company more flexibility in issuing shares but may dilute existing shareholders.)

Year-Over-Year Comparison

The DEF 14A filing indicates a strategic shift in executive compensation for fiscal year 2025, with a notable change in the weighting of Performance Share Units (PSUs) towards Adjusted EBITDA and Unlevered Adjusted Free Cash Flow (40% each) compared to the previous year's structure (45% each). Revenue weighting has increased to 20% from 10%. The filing also seeks renewed authorities for share issuance and preemption rights, suggesting a proactive approach to capital management and potential future financing needs.

Filing Stats: 4,645 words · 19 min read · ~15 pages · Grade level 14 · Accepted 2025-10-28 16:46:09

Key Financial Figures

Filing Documents

Executive Compensation Tables

Executive Compensation Tables 13 Pay Versus Performance 19 Proposal 4— Renew authority of our Board of Directors, until June 17, 2027, to issue ordinary shares 23 Proposal 5— Renew authority of our Board of Directors, until June 17, 2027, to opt out of statutory preemptive rights 24 Proposal 6— Reappoint our statutory auditor until our annual general meeting in 2026 25 Proposal 7— Authorize our Board of Directors to determine remuneration of our statutory auditor 26 Corporate Governance 27 Compensation of our Board of Directors 33

Security ownership of certain beneficial owners and management

Security ownership of certain beneficial owners and management 34 Questions and answers about the annual meeting and voting 36 Appendix A—Non-GAAP Financial Measures Appendix B—Form of Proxy ii INFORMATION ABOUT OUR DIRECTORS AND EXECUTIVE OFFICERS Our Board of Directors The Board of Directors of Cimpress plc (which is also referred to in this proxy statement as our Board of Directors or our Board) consists of four independent, non-employee directors and Robert S. Keane, our Chief Executive Officer and Chairman, who serve for rotating terms of three years. Additional information about our directors is as follows Name Age Board Position Cimpress Director Since Current Term Expires at our Annual General Meeting in Independent Director Robert S. Keane 62 Chairman January 1995 2025 No Sophie A. Gasperment 61 Non-Employee Director November 2016 2026 Yes Dessislava Temperley 52 Non-Employee Director September 2021 2027 Yes Wayne Ting* 41 Non-Employee Director May 2025 2027 Yes Scott J. Vassalluzzo 53 Non-Employee Director January 2015 2025 Yes _____________ * Mr. Ting was appointed to our Board on May 27, 2025. ROBERT S. KEANE has served as our Chief Executive Officer and Chairman since he founded Cimpress in January 1995. From 1988 to 1994, Mr. Keane was an executive at Flex-Key Corporation, an original equipment manufacturer of keyboards, displays and retail kiosks used for desktop publishing. Since December 2019, Mr. Keane has also served on the Board of Directors of Astronics Corporation, a supplier to the aerospace industry. Mr. Keane brings to Cimpress' Board his experience growing Cimpress from inception in 1995 to $3.4 billion of revenue in our 2025 fiscal year and his knowledge of Cimpress' customer needs, business model and markets. SOPHIE A. GASPERMENT has served as Senior Advisor to Boston Consulting Group since November 2019, where she supports their Consumer and Digital Acceleration practices, and has also provided strategy cons

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing